View in EDS

Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03.

Saved in:
Bibliographic Details
Title: Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03.
Authors: Saura, C.1 (AUTHOR) csaura@vhio.net, Cortés, J.2,3,4,5,6 (AUTHOR), Modi, S.7 (AUTHOR), Kim, S.-B.8 (AUTHOR), Hamilton, E.9 (AUTHOR), Hurvitz, S.A.10 (AUTHOR), Krop, I.E.11 (AUTHOR), Curigliano, G.12,13 (AUTHOR), Iwata, H.14 (AUTHOR), Im, S.-A.15 (AUTHOR), Herbolsheimer, P.16 (AUTHOR), Karnoub, M.17 (AUTHOR), Boran, A.17 (AUTHOR), Kuwahara, Y.17 (AUTHOR), Egorov, A.17 (AUTHOR), André, F.18 (AUTHOR)
Source: Annals of Oncology. Mar2026, Vol. 37 Issue 3, p353-363. 11p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 191526999
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Saura%2C+C%2E%22">Saura, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> csaura@vhio.net</i><br /><searchLink fieldCode="AR" term="%22Cortés%2C+J%2E%22">Cortés, J.</searchLink><relatesTo>2,3,4,5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Modi%2C+S%2E%22">Modi, S.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+S%2E-B%2E%22">Kim, S.-B.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hamilton%2C+E%2E%22">Hamilton, E.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hurvitz%2C+S%2EA%2E%22">Hurvitz, S.A.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Krop%2C+I%2EE%2E%22">Krop, I.E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Curigliano%2C+G%2E%22">Curigliano, G.</searchLink><relatesTo>12,13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Iwata%2C+H%2E%22">Iwata, H.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Im%2C+S%2E-A%2E%22">Im, S.-A.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Herbolsheimer%2C+P%2E%22">Herbolsheimer, P.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Karnoub%2C+M%2E%22">Karnoub, M.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boran%2C+A%2E%22">Boran, A.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuwahara%2C+Y%2E%22">Kuwahara, Y.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Egorov%2C+A%2E%22">Egorov, A.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22André%2C+F%2E%22">André, F.</searchLink><relatesTo>18</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. Mar2026, Vol. 37 Issue 3, p353-363. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=191526999
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2025.11.007
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 353
    Titles:
      – TitleFull: Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Saura, C.
      – PersonEntity:
          Name:
            NameFull: Cortés, J.
      – PersonEntity:
          Name:
            NameFull: Modi, S.
      – PersonEntity:
          Name:
            NameFull: Kim, S.-B.
      – PersonEntity:
          Name:
            NameFull: Hamilton, E.
      – PersonEntity:
          Name:
            NameFull: Hurvitz, S.A.
      – PersonEntity:
          Name:
            NameFull: Krop, I.E.
      – PersonEntity:
          Name:
            NameFull: Curigliano, G.
      – PersonEntity:
          Name:
            NameFull: Iwata, H.
      – PersonEntity:
          Name:
            NameFull: Im, S.-A.
      – PersonEntity:
          Name:
            NameFull: Herbolsheimer, P.
      – PersonEntity:
          Name:
            NameFull: Karnoub, M.
      – PersonEntity:
          Name:
            NameFull: Boran, A.
      – PersonEntity:
          Name:
            NameFull: Kuwahara, Y.
      – PersonEntity:
          Name:
            NameFull: Egorov, A.
      – PersonEntity:
          Name:
            NameFull: André, F.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2026
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 37
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1